Auto PBSCT:Efficacy of Autologous Peripheral Blood Stem Cell ...
Efficacy of Autologous Peripheral Blood Stem Cell ...
由SGronier著作·2013—CONCLUSIONS:Auto-PBSCTinPOEMSsyndromeresultstoobviousbothclinicalandelectrophysiologicalimprovementofperipheralneuropathywithinoneyearafter ...。其他文章還包含有:「Autologousperipheralbloodstemcelltransplantation...」、「Autologousperipheralbloodstemcelltransplantationin...」、「Comparisonofthetransplantoutcomesbetweenauto」、「DefinitionofPBSCT」、「Mobilizationofperipher...
查看更多 離開網站Autologous peripheral blood stem cell transplantation ...
https://pubmed.ncbi.nlm.nih.go
Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in ...
Autologous peripheral blood stem cell transplantation in ...
https://pubmed.ncbi.nlm.nih.go
Comparing with conventional chemotherapy, our study suggests that auto-PBSCT is a very important therapeutic option that can significantly improve the ...
Comparison of the transplant outcomes between auto
https://www.researchgate.net
They showed that autologous PBSCT was associated with lower NRM and higher relapse rates than those associated with allogeneic PBSCT or BMT from MSD and ...
Definition of PBSCT
https://www.cancer.gov
A procedure in which a patient receives healthy blood-forming cells (stem cells) to replace their own stem cells that have been destroyed by disease or by ...
Mobilization of peripheral blood stem cells for autologous ...
https://www.sciencedirect.com
Autologous peripheral blood stem cells transplantation (Auto-PBSCT) is a therapeutic option which can be used in various hematological neoplastic disorders; ...
The Effectiveness of Upfront Auto PBSCT for the Treatment ...
https://www.annalsofoncology.o
The conditioning regimen for auto PBSCT was LEED therapy in all cases. The overall survival at 4 years was superior in the auto-PBSCT arm (75.0% versus 41.7% P ...
哪一種造血(幹) 細胞的捐贈來源,最適合用於血癌成人患者的 ...
https://www.cochrane.org
總而言之,我們發現PBSCT和BMT的整體和無疾病存活期相仿。相較於移植親屬捐贈之周邊血液幹細胞的患者,移植親屬捐贈之骨髓幹細胞的患者比較可能復發,但 ...
目前造血幹細胞移植在治療慢性骨髓性血癌的角色
http://www.tbmta.org.tw
• 週邊血液幹細胞移植(PBSCT) ... PBSCT 70% (n =142). P < 0.0001. 0 6 12 18 24 ... Chimeric antigen receptor (CAR) 驅動細胞. Page 39. Page 40. Page ...
認識造血幹細胞移植
http://www.tccf.org.tw
自1985年首例自體周邊血幹細胞移植(autologous PBSCT)成功後,即迅速為醫界所推崇,目前多利用自體周邊血幹細胞移植配合高劑量化療,用以治療乳癌、淋巴癌、孩童腫瘤等病患 ...